Australia’s Groundbreaking Stem Cell Sciences Closed By New U.S. Owner
This article was originally published in PharmAsia News
Executive Summary
Stem Cell Sciences, Australia's first stem-cell biotech, is going out of business, the result of a decision by its new U.S. owner. StemCells of California acquired the intellectual property of SCS for handling embryonic stem cells and other technology along with patents on 20 sets of products. The closing of SCS leaves Australia with only Mesoblast, since Bresagen ended its stem-cell work and Embryonic Stemcells relocated to Singapore. The California company bought SCS in March for $4 million. (Click here for more